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Lactobacilli predominate normal vaginal microflora and are important in maintenance of vaginal health. 
The current study set out to identify and compare culture isolates of vaginal microflora of human 
immunodeficiency virus (HIV) positive (HIV
+
) and HIV negative (HIV
-
) women at different phases during 
menstrual cycle from a sub-urban population of Kenya. Seventy four (74) women, 41 HIV
+
 and 33 HIV
-
, 
followed up two consecutive menstrual cycles, had high vaginal swabs taken to prepare Gram stains for 
six visits and anaerobic cultures for four. All 751 isolates identified by t-DNA polymerase chain reaction 
(PCR) belong to 51 species. Species cultured more frequently in HIV
+
 participants were: Lactobacillus 
jensenii (p=0.01), Lactobacillus iners (p=0.02), Gardnerella vaginalis (p=0.01) and Peptoniphilus 
lacrimalis (p=0.01). Species cultured more frequently in HIV
-
 women were Dialister micraerophilus 
(p=0.02) and Streptococcus agalactiae (p=0.04). Lactobacillus predominating both groups were 
Lactobacilli crispatus, L. jensenii, L. iners and Lactobacilli vaginalis. Bacterial vaginosis (BV) was 
equally high in HIV
+
 and HIV
-
 women. Lactobacillus and BV-associated species were cultured more 
frequently in HIV
+
 women. Minor species differences were found. Predominant Lactobacillus in culture 
were L. crispatus, L. iners, L. jensenii and L. vaginalis. These women had lower concentrations of 
lactobacilli in vaginal microflora than observed in previous studies of Caucasian women. 
 
Key words: Vaginal microflora, human immunodeficiency virus (HIV), menstrual cycle, t-DNA polymerase chain 
reaction (PCR), culture, bacterial vaginosis. 
 
 
INTRODUCTION 
 
Perturbation of the healthy vaginal ecosystem, also  by loss of hydrogen peroxide (H2O2)-producing 
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sodium dodecyl sulfate. 
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referred to as bacterial vaginosis (BV), is characterized 
lactobacilli and massive overgrowth of Gardnerella 
vaginalis and other Gram positive and negative anaerobic 
bacteria (Marrazzo, 2004). Of concern are recent 
observations that BV predisposes to acquisition of 
sexually transmitted infections (STIs), which raises the 
risk of mother-to-child transmission of human 
immunodeficiency virus (HIV). Diminished colonisation 
resistance during BV renders women vulnerable to 
various infections such as Trichomonas  vaginalis and 
Neisseria gonorrhoeae (Martin et al., 1999; Wiesenfeld et 
al., 2003), Chlamydia trachomatis (Wiesenfeld et al., 
2003), genital herpes simplex (Kaul et al., 2007), human 
papillomavirus (Watts et al., 2006) and HIV-1 (Spear et 
al., 2007; Atashili et al., 2008). Further, it is documented 
that BV propagates replication and vaginal shedding of 
the HIV-1 (Sha et al., 2005) and HSV-2 viruses (Cherpes 
et al., 2005), thus enhancing the spread of STIs. 
Increased mother-to-child transmission of HIV as a 
consequence of BV has been documented in a 
prospective study of 463 HIV-1-infected mothers and 
infants in Kenya (Farquhar et al., 2010). This study found 
women with BV to be three times more likely to transmit 
HIV in utero. High prevalence of BV in sub-Saharan 
Africa (Sewankambo et al., 1997; Taha et al., 1998; 
Paxton et al., 1998; Martin et al., 1999; van de Wijgert et 
al., 2000; Demba et al., 2005; Morison et al., 2005; 
Bukusi et al., 2006; McClelland et al., 2009) has therefore 
become an issue of global concern. It is estimated, for 
instance, that in endemic areas, nearly one-third of new 
HIV cases could be prevented if existing BV were cured 
(Schwebke, 2005). Tackling the HIV burden through 
eradicating BV and restoring normal vaginal microflora is 
currently considered part of the most promising answers 
to the HIV pandemic (Martin et al., 1999; Shin and Kaul, 
2008; Bolton et al., 2008). 
The last two decades have seen a significant increase 
in the volume of research focusing on BV and com-
position of vaginal microflora (Verhelst et al., 2005; Kalra 
et al., 2007; Srinivasan et al., 2010; Verstraelen et al., 
2010). The prevalence of BV varies widely in different 
populations. It tends to be high in African women, with 
rates up to 44% having been documented in a Kenyan 
cohort and 50% in rural Uganda (Paxton et al., 1998; 
Bukusi et al., 2006). Studies found African American 
women to have more than two-fold higher prevalence of 
BV compared to Caucasian American women. The cause 
of this disparity remains unknown (Goldenberg et al., 
1996; Pastore et al., 1999; Royce et al., 1999; Ness et 
al., 2003; Allsworth and Peipert, 2007). Studies show 
African women to be either less likely to harbor H2O2-
producing lactobacilli which are known to suppress 
growth of anaerobic bacteria (Antonio et al., 1999) or to 
have lower concentrations of the same (Anukam et al., 
2006; Zhou et al., 2007; McClelland et al., 2009). African 
women also tend to have significantly higher vaginal pH 
than do Caucasian women (Ravel et al., 2010). In 
addition, the  prevalence  of  BV has  been  shown to be  
 
 
 
 
higher in HIV-infected women compared to HIV-
uninfected women (Sewankambo et al., 1997; Jamieson 
et al., 2001; Warren et al., 2001). From the foregoing 
information, it is apparent that more studies are needed 
to complete our understanding of BV in affected sub-
populations. Further, it is not known how vaginal 
microflora varies during the phases of the menstrual 
cycle. 
The goal of the present study was to investigate the 
composition of vaginal microflora of non-pregnant 
premenopausal HIV
+
 and HIV
-
 women in a sub-urban 
population of Kenya by PCR-based identification of 
culture isolates obtained during the follicular and 
ovulation phases of the normal menstrual cycle. 
 
 
MATERIALS AND METHODS 
 
Study population 
 
This was a cross-sectional study nested in an on-going Tigoni 
dysplasia study (TDS) based at Tigoni Hospital, Kiambu West 
district of Kenya. Recruitment of participants took place at the 
hospital between August 2006 and March 2008. Of the 215 women 
screened, 100 of them met the inclusion criteria, and only 74 
returned for the scheduled six follow-up visits. Specimens were 
collected at three points of two consecutive menstrual cycles– 
follicular (day 5-8), ovulation (day 12-15) and luteal (day 19-22) 
phases. At each phase, the sampling period was spread out within 
four days to create flexibility for return visits. The participants were 
asked to mark all the days of menstrual bleeding as a guide to 
establishing the regularity of the cycle. Following verbal explanation 
of the study objectives, written consent to participate was obtained 
for all participants and hard copies of the study explanation issued 
to them. The documents were available in both English and the 
most widely used local language, Kiswahili. The study was 
approved by the ethical review board of Kenyatta National Hospital/  
University of Nairobi (Registration number P122/8/2005). 
During the study, all STIs diagnosed were treated according to 
the Kenya Ministry of Health national guidelines (2007) for both 
participants and those excluded from the study. All HIV
+
 women 
received treatment free of charge, courtesy of the sponsored 
partnership of Kenya Ministry of Health, University of Nairobi 
Institute of Tropical and Infectious Diseases and Pathfinder 
International. At the time of the study, all HIV
+
 persons with a CD4 
count above 200 cells/ mm
3
 were exempted from antiretroviral 
therapy (ART) according to WHO guidelines (1997). Qualifying pre-
menopausal women, aged between 18 and 45 years were screened 
for eligibility using a standard face-to-face questionnaire interview. 
The HIV
+ 
women who had CD4 counts above 250 cells/mm
3
 and not 
undergoing ART were recruited. All the participants had regular 
menses and a documented normal papanicolaou (pap) smear test 
result performed within one year. 
The exclusion criteria were presence of STIs, ongoing pregnancy, 
use of contraception except condom, previous hysterectomy, 
delivery or abortion in the preceding three months and use of 
systemic antibiotics (except cotrimoxazole prophylaxis for HIV
+
 
women given under Kenya national guidelines for HIV 
management). The HIV test was performed in order to group 
patients as positive and negative. 
Following the face-to-face questionnaire interview, subjects 
provided blood specimens for HIV testing, syphilis and CD4 count. 
Vaginal specimens were taken to test for T. vaginalis, C. 
trachomatis and N. gonorrhoeae. HIV pre- and post-test counselling 
was offered by a trained nurse. 
 
 
 
 
Screening tests 
 
Study participants were screened for HIV-1 infection using enzyme-
linked immunosorbent assay (ELISA) Detect-HIV (BioChem 
ImmunoSystems, Allentown, PA). Positive samples were confirmed 
by a second ELISA (Vironostika, BioMérieux, Marnes-la-Coquette, 
France) (WHO guidelines). Urine pregnancy test was performed 
using a rapid β–hCG test kit (Plasmatec Laboratory products, 
Cambridge, UK) and syphilis seroreactivity assessed by the Rapid 
Plasma Reagin (Becton Dickinson, Baltimore, MD). Confirmatory 
Treponema pallidum haemagglutination assay was not necessary 
as no seroreactive cases were detected. Two high vaginal swabs 
were taken for T. vaginalis culture (In-Pouch, Biomed Diagnostics, 
San Jose, CA) and for diagnosis of candidiasis assessed by 
microscopic examination for presence of budding yeasts or 
pseudohyphae in a drop of 10% KOH. One endocervical swab was 
required for combined C. trachomatis and N. gonorrhoeae 
polymerase chain reaction (PCR) (Cobas Amplicor, Roche 
Diagnostics, Basel, Switzerland). The CD4 count was performed by 
flow cytometry using specific antibodies (Becton Dickinson), and 
stained samples analysed using a FacsCaliber instrument and the 
CELLQuest Software (Becton Dickinson). 
 
 
Follow-up sample collection 
 
The 74 women (41 HIV
+
 and 33 HIV
-
) followed up had two high 
vaginal swabs taken at subsequent visits as follows: with a non-
lubricated speculum in place, sterile cotton swabs were 
consecutively inserted into the vaginal vault. Each swab was 
rotated against the lateral vaginal wall at the mid-portion of the vault 
and carefully removed to prevent contamination with the vulva and 
introitus microflora. The first swab was used to make a Gram stain. 
The second swab was carried to the laboratory in Amies transport 
medium (Nuova Aptaca, Canelli, Italy) for anaerobic culture which 
was performed at follicular (day 5-8) and ovulation (day 12-15) 
phases. Culture swabs were processed in the microbiology 
laboratory within 4 h of collection. Gram stain specimens were 
analysed for the composition of the vaginal microflora by 
microscopy according to the Nugent criteria (Nugent et al., 1991). 
An additional category of the gram stains known as grade 0 was 
included to represent the smears lacking bacteria cells. 
 
 
Culture and identification of isolates 
 
The swabs were streaked onto Columbia agar (Becton Dickinson) 
supplemented with 5% sheep blood (obtained freshly defibrinated 
from the Kabete Veterinary farm, University of Nairobi, Kenya) and 
incubated anaerobically (GasPak EZ Anaerobe Container System) 
at 37°C. After 4 days of incubation, all isolates with different colony 
morphology were selected for species identification. DNA was 
extracted by simple alkaline lysis as follows: each colony selected 
for its unique morphology was suspended in 20 µl sodium dodecyl 
sulfate (SDS) lysis buffer (0.25% sodiumdodecylsulphate in 0.05 N 
NaOH), heated at 95°C for 15 min and diluted with 180 µl double 
distilled water. The t-DNA-PCR and capillary electrophoresis were 
carried out as described previously (Baele et al., 2000; Baele et al., 
2002). Species identification of culture isolates was achieved by 
comparing their respective t-DNA-PCR fingerprints with an existing 
t-DNA-PCR database using an in-house software program (Baele et 
al., 2002). The t-DNA-PCR fingerprint database and the software 
are available upon request to Laboratory for Bacteriology Research, 
Ghent University, Belgium, where the PCR work was carried out. 
Isolates that could not be identified in the existing t-DNA-PCR 
database were sequenced as earlier described (Verhelst et al., 
2004). 
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Statistical analysis 
 
Prevalence rates were compared between groups through Chi-
square test or Fischer's Exact Test. Statistical significance was 
accepted at the significance level α=0.05. All analyses were 
performed with statistical software package PASW v18.0 (Chicago, 
IL). 
 
 
RESULTS 
 
Cohort characteristics 
 
Baseline demographic characteristics of 41 HIV
+
 and 33 
HIV
-
 women are presented in Table 1. All participants 
were literate and able to follow the appointment schedule. 
At enrolment, no significant difference existed in most 
parameters measured in the two groups. The HIV
+
 
women had lower CD4 counts (p<0.001) and condom use 
was more common among them (61%) compared to the 
HIV
-
 women (18.2%) (p=0.0002). Intake of antibiotic 
prophylaxis was only in the HIV
+
 group at 78% (p<0.001). 
The Kenya national guidelines for treatment and care for 
HIV persons allows continuous antibiotic intake for 
prevention of malaria and recurrent bacterial infections. 
Of the HIV
+
 participants, 63.4% were married compared 
to 39.4% HIV
-
 ones (p=0.001). The HIV
+ 
women had 
lower levels of schooling (p=0.005). 
 
 
Vaginal microflora and HIV status 
 
Bacterial vaginosis was diagnosed in 17.5% enrolment 
visits. Table 2 shows the fluctuation in Gram stain score 
over two menstrual cycles. Respectively 42.4% of HIV
- 
and 31.7% of HIV
+
 women harboured a normal vaginal 
microflora on all six visits. As shown in Table 3, the 
number of vaginal swabs with grades I, II and III was 
similar throughout the phases of the menstrual cycle in 
both study groups. 
 
 
Presence of bacterial species according to HIV status 
 
Species cultured and identified in the HIV
+
 and HIV
-
 
women are presented in Table 4 and Figure 1. In total, 
1020 isolates were cultured. Of these, 26% of the isolates 
remained unidentified either because no corresponding t-
DNA-PCR fingerprint was found in the existing database 
or no amplification obtained. In total, 51 species were 
identified, nine of which belonged to the genus 
Lactobacillus, that is, L. coleohominis, L. crispatus, L. 
gasseri, L. iners, L. jensenii, L. mucosae, L. reuteri, L. 
salivarius and L. vaginalis. In descending order, the most 
common lactobacilli were L. crispatus, L. iners, L.  
jensenii and L. vaginalis. Respectively, 54.5% of HIV
- 
and 
60.9% of HIV
+
 women were colonized by lactobacilli at 
least one visit, and 9.1 and 29.3% at least three visits. 
Lactobacillus crispatus was cultured on three out of four
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Table 1. Descriptive characteristics of the study population at enrolment, expressed as percentages.  
 
Parameter Category HIV
+
 (41) HIV
-  
(33)
 
p value 
Age (years) 
21-28 14.6 24.2 0.4 
29-36 53.7 39.4  
37-44 31.7 36.4  
     
CD4 count (cells/μL) 
250-500 56.1 3.0 < 0.001 
501-750 31.7 15.2  
751-1000 7.3 54.5  
1001-1500 4.9 27.3  
     
Vaginal pH 
3.0-4.5 73.2 63.6 0.4 
> 4.5 26.8 36.4  
     
Candida 
Positive 36.6 27.3 0.4 
Negative 63.4 72.7  
     
Gram stain 
Grade 0 9.8 6.1 0.7 
Grade I 56.1 72.7  
Grade II 9.8 6.1  
Grade III 22.0 12.2  
No score 2.4 3.0  
     
Antibiotic prophylaxis 
Yes 78.0 0.0 <0.001 
No 22.0 100.00  
     
Systolic Blood Pressure (mm Hg) 
90-110 34.1 30.3 0.8 
111-130 51.2 48.5  
131-150 12.2 15.2  
151-170 2.4 3.0  
> 170 0.0 3.0  
     
Diastolic Blood Pressure (mm Hg) 
60-69 12.2 15.2 0.8 
70-79 43.9 36.4  
80-89 29.3 27.3  
90-99 14.6 18.2  
> 100 0.0 3.0  
     
Pulse (beats/min) 
< 60 0.0 3.0 0.3 
60-69 9.8 24.2  
70-79 39.0 30.3  
80-89 36.6 33.3  
90-99 14.6 6.10  
> 100 0 3.0  
     
Height (cm) 
130-144 2.4 0.0 0.4 
145-159 46.3 30.3  
160-174 48.8 66.7  
> 175 2.4 3.0  
     
Body weight (kg) 
45-54 26.9 18.2 0.3 
55-64 26.9 36.4  
65-74 31.7 18.2  
75-84 12.2 15.2  
85-94 0 9.1  
> 95 2.4 3.0  
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Table 1. Contd. 
 
Parameter Category HIV
+
 (41) HIV
-  
(33)
 
p value 
Age at first sex (years) 
14-15 9.8 6.1 0.7 
16-18 43.9 36.4  
19-23 31.7 33.3  
24-28 12.2 18.2  
> 29 0 3.0  
N/A 2.4 3.0  
     
Lifetime partners 
0-1 19.5 27.3 0.3 
2-3 48.8 42.4  
4-7 24.4 30.3  
8-10 7.3 0.0  
     
Current partners 
0 24.4 30.3 0.6 
1 75.6 69.7  
     
Marital status 
Married 63.4 39.4 0.001 
Single/Separated 22.0 60.6  
Widow 14.6 0  
     
Condom use 
Yes 61.0 18.2 <0.001 
No 39.0 81.8  
     
Level of schooling 
Primary and below 46.3 12.2 0.005 
Secondary 51.2 78.8  
Tertiary 2.4 9.1  
     
Occupation 
Housewife 36.6 30.3 0.2 
Farmer 14.6 6.10  
Business 24.4 15.2  
Formal employment 24.4 42.4  
Student 0 6.10  
 
 
 
Table 2. Percentages of the fluctuation of the Gram stain scores of HIV
- 
and HIV
+
 women taken at six visits each, spanning two 
menstrual cycles. 
 
Parameter HIV 
-
 HIV 
+
 
Condom use (total number) No (27) Yes (6) No (17) Yes (24) 
Invariably normal 33.3 83.3 47.1 20.8 
Single intermediate or BV episode 11.1 16.7 11.8 29.2 
Two intermediate or BV episodes 14.8 0 5.8 0 
Three or more intermediate or BV episodes 29.6 0 17.6 37.5 
Invariably intermediate or BV episode 11.1 0 17.6 12.5 
 
 
 
Table 3. Distribution of Nugent scored vaginal microflora grades among HIV
+
 and HIV
-
 women during different phases of two menstrual 
cycles. Percentages in parentheses. 
 
Grade 
HIV
 + 
(n = 41) HIV 
- 
(n = 33) 
Follicular Ovulation Luteal Follicular Ovulation Luteal 
0 2 (2.4) 4 (4.9) 0 (0.0) 1 (1.5) 1 (1.5) 0 (0.0) 
I 42 (51.2) 49 (59.8) 53 (64.6) 41 (62.1) 45 (68.2) 44 (66.7) 
II 18 (22.0) 12 (14.6) 15 (18.3) 11 (16.7) 8 (12.1) 9 (13.6) 
III 17 (20.7) 16 (19.5) 14 (17.1) 11 (16.7) 12 (18.2) 11 (16.7) 
Missing 3 (3.7) 1 (1.2) 0 (0.0) 2 (3.0) 0 (0.0) 2 (3.0) 
Total 82 82 82 66 66 66 
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Table 4. Percentage of 250 visits during which 44 HIV
+
 and 33 HIV
-
 women with a positive culture. 
 
Species HIV
+
women
a
 HIV
-
 women
b
 P value 
Acinetobacter haemolyticus 1.4 0 0.2 
Acinetobacter lwoffii 0.7 0 0.3 
Anaerococcus prevotii 2.1 4.6 0.2 
Anaerococcus tetradius 0.7 0 0.3 
Anaerococcus vaginalis 0.7 0.9 0.4 
Atopobium vaginae 0 0.9 0.2 
Bacteroides coagulans 0.7 0 0.3 
Bacteroides ureolyticus 0.7 0.9 0.4 
Clostridia bacterium 0.7 0 0.3 
Dialister micraerophilus 0 3.7 0.02 
Enterococcus faecalis 7.7 14.8 0.07 
Escherichia coli 9.2 10.2 0.7 
Finegoldia magna 16.2 22.2 0.2 
Gardnerella vaginalis 12 3.7 0.01 
Klebsiella pneumoniae 0.7 0 0.3 
Lactobacillus coleohominis 0 1.9 0.09 
Lactobacillus crispatus 11.3 14.8 0.4 
Lactobacillus gasseri 1.4 1.9 0.7 
Lactobacillus iners 15.5 6.5 0.02 
Lactobacillus jensenii 13.4 4.6 0.01 
Lactobacillus mucosae 0.7 0 0.3 
Lactobacillus reuteri 0 1.9 0.09 
Lactobacillus salivarius 2.8 0 0.07 
Lactobacillus vaginalis 7.7 4.6 0.3 
Mobiluncus curtisii 0.7 0 0.3 
Peptoniphilus asaccharolyticus 27.5 29.6 0.7 
Peptoniphilus lacrimalis 7 0.9 0.01 
Peptoniphilus sp. 0.7 2.8 0.1 
Peptostreptococcus anaerobius 13.4 14.8 0.7 
Peptostreptococcus hydrogenalis 0.7 0 0.3 
Peptostreptococcus indolicus 0 0.9 0.2 
Porphyromonas somerae 0.7 1.9 0.3 
Porphyromonas sp. 0 0.9 0.2 
Prevotella bivia 12.7 13 0.9 
Prevotella buccalis 3.5 0.9 0.1 
Prevotella corporis 0.7 2.8 0.1 
Prevotella disiens 2.1 0 0.1 
Prevotella timonensis 0.7 1.9 0.3 
Propionibacterium acnes 0.7 0 0.3 
Pseudomonas mendocina 0 0.9 0.2 
Staphylococcus aureus 0.7 1.9 0.3 
Staphylococcs epidermidis 17.6 19.4 0.7 
Staphylococcus hominis 1.4 0 0.2 
Streptococcus agalactiae 4.9 12 0.04 
Streptococcus anginosus 9.9 9.3 0.8 
Streptococcus mitis 2.1 3.7 0.4 
Streptococcus salivarius 0.7 0 0.3 
Streptococcus sp. 0.7 0 0.3 
Ureaplasma parvum 0.7 0 0.3 
Veillonella atypica 5.6 11.1 0.1 
Veillonella parvula 0.7 0 0.3 
 
a
142 visits; 
b
108 visits. 
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Figure 1. Bacterial species present in more than 2% of the 74 women studied. 
 
 
 
visits for two women and it occurred twice in five women 
and once in 11 women. Lactobacillus iners was cultured 
on three visits for two women, twice in two women and 
only once in 13 women. Lactobacillus jensenii was 
recovered on three out of four visits in five women, on 
two visits in two women and one visit in four women. Two 
species occurred more frequently in the HIV+ women 
compared to HIV- women: L. iners (15.5% vs 6.5%; 
p=0.02) and L. jensenii (13.4% vs 4.6%; p=0.01). G. 
vaginalis and P. lacrimalis occurred more frequently in 
HIV
+
 women (respectively 12% vs 3.7% and 7% vs 0.9%; 
p=0.01). D. micraerophilus was found more frequently in 
the   HIV
-
   group   (3.7%   vs   0%;   p=0.02)  as   was  S.  
agalactiae (12% vs 4.9%; p=0.04). 
 
 
DISCUSSION 
 
The objective of this study was to compare vaginal 
microflora of HIV
+
 and HIV
- 
Kenyan women of 
reproductive age by means of culture and Nugent scoring 
of Gram stains. There were existing differences in the 
species present in the two groups of women. This 
confirms findings of Spear et al. ( 2008) who identified a 
trend towards increased diversity in HIV
+
 women, 
suggesting  that  HIV  infection  may  be  associated  with 
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changes in the diversity of genital microflora. 
Presence of BV has been associated with increased 
susceptibility to acquisition of STIs (Martin et al., 1999; 
Sewankambo et al., 1997; Kaul et al., 2007). Since BV 
increases the risk of HIV acquisition, it would be expected 
that higher rates of BV be confirmed among HIV
+
 women. 
However, in this study, no significant difference was 
found in the rates of BV in HIV
+
 and HIV
- 
women. This 
agrees with findings of Demba et al. (2005) and Watts et 
al. (2006), but is in contradiction to observation of other 
researchers (Jamieson et al., 2001; Sewankambo et al., 
1997; Warren et al., 2001) who found prevalence of BV to 
be higher among HIV-infected women compared to HIV-
uninfected women. 
Possible explanation for the lack of correlation between 
the prevalence of BV and HIV status observed in the 
current study may be due to differences in antibiotic 
intake between HIV
+
 and HIV
- 
women. The imbalance of 
vaginal microflora in this HIV
+
 group may further be 
explained by the fact that 78% of them were on co-
trimoxazole (trimethoprim-sulfamethoxazole) prophylaxis. 
Although this antibiotic has been shown to reduce 
mortality of HIV patients and to have a beneficial effect by 
decreasing the rate of CD4 cell depletion (Mermin et al., 
2004), use of antibiotics decimates H2O2-producing 
lactobacilli in the vagina (Vallor et al., 2001; Hummelen et 
al., 2010). Co-trimoxazole is the prophylaxis antibiotic 
approved by the Kenya Ministry of Health (2007) and is 
readily available to HIV
+
 persons in health centers. It is 
used similarly in other sub-Saharan African countries 
(Hamer and Gill, 2008). Since the HIV
+
 women continue 
to have more lactobacilli despite continuous intake of co-
trimoxazole, it is suggested that resistance to this 
antibiotic may have been attained. A previous study 
found that women with BV have decreased colonization 
rates for H2O2-producing strains of lactobacilli and 
increased colonization rates for non-H2O2-producing 
strains (Onderdonk et al., 2003; Ferris et al., 2007). This 
observation is supported by the present findings that L. 
iners, G. vaginalis and P. lacrimalis occurred more 
frequently in HIV
+
 women regularly using antibiotics. 
Some studies found infection with HIV-1 to be 
associated with abnormal vaginal microflora. 
Sewankambo et al. (1997) who studied 4718 women in a 
community survey in rural Uganda, concluded that loss of 
lactobacilli or presence of BV may increase susceptibility 
to acquisition of HIV-1. Jamieson et al. (2001) and 
Warren et al. (2001) while studying different aspects of a 
comparable high-risk cohort of 1288 women in the USA, 
found HIV infection to be positively correlated with 
presence of BV. However, they could not determine 
whether HIV-infected women have a higher incidence of 
BV or more persistent infections. Participants of the said 
study were not excluded on account of low CD4 counts or 
other STIs like in the current one. Jamieson et al. (2001) 
found that immunocompromised women (CD4 cell count < 
200 cells/μL) were more likely to have prevalent and 
persistent BV than  HIV-infected  women with higher  CD4  
 
 
 
 
cell counts (>500 cells/μL), but not more likely to have 
incident infections. This could be explained by the fact 
that the immunocompromised women were probably on 
HAART and the accompanying cotrimoxazole prophylaxis 
(Hamer and Gill, 2008; Watts et al., 2006). In the current 
cohort, none of the 74 women were immunocompromised 
or on ART, as illustrated by the fact that, of the 41 HIV
+
 
women, 56.1% had CD4 cell count in the range 250-500 
cells/μL and the rest in the range 501-1500 cells/μL. 
Further to the differences in immune status and 
therapeutic intervention between the two study groups, 
differences in sexual dynamics may also play a role. At 
the time of the study, most of the HIV-infected women 
had one (75.6%) or no (24.4%) sexual partners while 
63.4% were married. This may partly explain why no 
differences were detected in the prevalence of BV 
between the HIV- infected and uninfected subjects. 
Confounders not measured but varying between 
populations may also contribute to the difference in 
findings. In the current study more HIV
+
 women were 
married, which may imply that marriage increased the risk 
of exposure to HIV infection in this population. This 
finding is consistent with data obtained by the Kenya Aids 
Indicator Survey (KAIS, 2007). Compared to the HIV
- 
group, the HIV
+ 
women had lower levels of schooling, 
which may contribute to the observed lower rate of formal 
employment of HIV
+
 women (24.4% compared to 42.4% 
HIV
- 
women). A previous study in Kenya (Steele et al., 
2004) found genital hygiene practices to be associated 
with resource access factors such as higher education 
and income. Further, a more recent study clearly shows 
low socio-economic status to be associated with 
prevalence of BV in African American women (Allsworth 
and Peipert, 2007). The presence of BV is believed to 
predispose women to acquisition of HIV-1 (Sewankambo 
et al., 1997), whereas the psychosocial stress created by 
being HIV infected could predispose to acquisition of BV 
(Nansel et al., 2005), thus creating a complex inter-
relationship between the two infections. 
In agreement with other culture-based studies of 
African populations (Martin et al., 1999; McClelland et al., 
2009), the concentrations of vaginal Lactobacillus 
species were comparatively low, and prevalence of 
abnormal vaginal microflora and BV-associated species 
high in the current study group. High rates of BV were 
previously observed in cohorts of African women 
(Sewankambo et al., 1997; Taha et al., 1998) and in 
Kenya (Bukusi et al., 2006; McClelland et al., 2009). It 
appears, therefore, that African women have lower 
concentration of lactobacilli in their vaginal microflora, 
which may explain the high rates of BV in this population. 
Reasons for this are unclear, although vaginal hygiene 
practices and sexual behaviour may play a role. No 
significant effect of the menstrual cycle on the prevalence 
of BV was observed. Earlier studies found quantities of 
lactobacilli to decrease during menstruation (Keane et al., 
1997) and vaginal microflora to be more unstable during 
the  first  week  (Morison et al., 2005). The  current  study 
 
 
 
 
found almost equal numbers of grade I to III samples 
evenly spread out in the three sampling points at follicular 
(day 5-8), ovulation (day 12-15) and luteal (day 19-22) 
phases. This difference in observations may be explained 
by the varying time frame of sample collection in the 
current study. Keane et al. (1997) had a daily collection of 
the vaginal swabs while Morison et al. (2005) collected a 
sample on alternate days. As recent report by Brotman et 
al. (2010) showed that episodes of BV may be missed if 
specimens are collected at weekly or monthly intervals 
since fluctuations occur more frequently, and in some 
episodes remission may occur without intervention. 
However the current study had the strength of having 
accounted for most known behavioural confounders 
commonly associated with increased dynamism of the 
vaginal microflora (such as age, douching, contraceptive 
use, vaginal lubricants, irregular condom use, STIs and 
multiple partners) (Schwebke et al., 1999). This makes 
the observation of almost equal numbers of grade I to III 
samples evenly spread out in the three sampling points of 
the menstrual cycle more reliable. 
Demba et al. (2005), also using culture methods, found 
Prevotella and Bacteroides species to occur more 
frequently in Nigerian HIV
+
 women. The current study 
found these species to be equally distributed among both 
HIV
+
 and HIV
- 
groups. Other bacteria isolated in the 
vaginas of the participants that are not associated with 
normal vaginal microflora include the streptococci. S. 
agalactiae was most common in the HIV
-
group. Most of 
the other species identified occurred at more or less the 
same frequency in the two groups, and in other cases 
where a species was altogether absent in one group, 
statistical significance in the differences was not attained. 
The finding that the most abundant Lactobacillus 
species in the grade I category were L. iners (17.1%), L. 
crispatus (16.4%), L. jensenii (12.5%) and L. vaginalis 
(9.2%), in that order, are largely in agreement with 
previous studies of African women. In Nigeria, using 
denaturing gradient gel electrophoresis, one group 
(Anukam et al., 2006) found L. iners and L. gasseri to be 
the predominant species while in Uganda others (Jin et 
al., 2007) found L. reuteri, L. crispatus, L. vaginalis and L. 
jensenii to be most abundant using culture and PCR 
identification as in the current study. A more recent study 
conducted in Kenya (Matu et al., 2009) found L. jensenii 
to be the most abundant species using culture and 
phenotypic identification methods. In Belgian women, L. 
iners is more dominant in altered vaginal microflora (De 
Backer et al., 2007). One group (Anukam et al., 2005; 
Anukam et al., 2006) did not however detect lactobacilli in 
BV cases whereas in the current study, of the nine 
Lactobacillus species detected, eight of them were 
present in the non-grade I samples. The causes of racial 
difference in concentrations of lactobacilli remain 
unknown. A highly intriguing observation came from a 
study of Nigerian women (Anukam et al., 2006) that 
found only 3% of the healthy vaginal microflora to be 
dominated  by L. crispatus,  while L. iners was present  in 
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64%. Overall African women tend to have lower 
concentrations of lactobacilli (McClelland et al., 2009). 
This observation may be a possible explanation for the 
high prevalence of BV among African women (Allsworth 
and Peipert, 2007; Bukusi et al., 2006) since it is known 
that most L. iners strains are very weak H2O2 producers. 
In contrast, L. crispatus is known to produce large 
amounts of H2O2 and as such provides better 
colonization resistance (Antonio et al., 1999; Vallor et al., 
2001; Verstraelen et al., 2009; Verstraelen et al., 2010). 
Low concentrations of lactobacilli in Kenyan women 
have been observed by other researchers (McClelland et 
al., 2009).  Further, among 185 and 241 Nigerian women 
respectively, two studies found 12 and 10 Lactobacillus 
spp. to be present (Anukam et al., 2005; Anukam et al., 
2006). An earlier study comparing Korean and Ugandan 
women found that vaginal microflora may vary in women 
of different geographical communities (Jin et al., 2007). In 
a US study African American women with BV were found 
to be predominantly colonized by Mobiluncus spp., based 
on gram staining (Royce et al., 1999). Researchers in 
Nigeria (Anukam et al., 2006) and The Gambia (Demba 
et al., 2005) found Mycoplasma hominis to be commonly 
associated with BV. In the present study Mobiluncus spp. 
was cultured in only one subject in the non-grade I 
category despite the observation of Mobiluncus–like 
organisms in the vaginal Gram-stained smears. M. 
hominis was not cultured at all. Although this could point 
to culture bias, the Demba group (Demba et al., 
2005)also failed to isolate Mobiluncus in the Nigerian 
population of 277 women using a 72 h incubation 
protocol. Like their group, the current study used 
Columbia blood agar and longer incubations of 96 h. 
Some species identified in greater proportions in either 
the HIV
+
 or HIV
- 
women did not attain statistical 
significance due to small sample size. Studies of this 
nature conducted on a larger sample size will help to 
draw conclusions on other types of microflora 
predominant in HIV
+
 and HIV
- 
women, thus enabling more 
specific approaches to probiotic therapy. Probiotic 
therapy may need to be geographically determined in 
order to take care of differences in the species and 
populations of Lactobacillus. Treating BV in HIV
+
 women 
would subsequently reduce the risk of mother-to-child-
transmission. 
 
 
Conclusions 
 
The current data provide evidence that differences exist 
in the species that colonize the vaginas of HIV
+
 and HIV
- 
women in the course of the normal menstrual cycle. BV 
was equally high in HIV
+
 and HIV
-
 women. Lactobacillus 
and BV-associated species were cultured more fre-
quently in HIV
+
 women. Predominant Lactobacillus in 
culture were L. crispatus, L. iners, L. jensenii and L. 
vaginalis. These Kenyan women had lower concen-
trations of lactobacilli in vaginal microflora than observed 
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in previous studies of Caucasian women. 
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